Treatment of Tardive Dyskinesia: A General Overview with Focus on the Vesicular Monoamine Transporter 2 Inhibitors Nicki NiemannJoseph Jankovic Therapy in Practice 26 February 2018 Pages: 525 - 541
Episodic Breathlessness in Patients with Advanced Cancer: Characteristics and Management Sebastiano Mercadante Review Article 22 February 2018 Pages: 543 - 547
BRAF and MEK Inhibitors: Use and Resistance in BRAF-Mutated Cancers Jaquelyn N. SanchezTon WangMark S. Cohen Review Article 27 February 2018 Pages: 549 - 566
Contemporary Drug Treatment of Hypertension: Focus on Recent Guidelines Wilbert S. AronowWilliam H. Frishman Review Article 13 March 2018 Pages: 567 - 576
Sofosbuvir/Velpatasvir/Voxilaprevir: A Review in Chronic Hepatitis C Young-A HeoEmma D. Deeks Adis Drug Evaluation 15 March 2018 Pages: 577 - 587
OnabotulinumtoxinA: A Review in the Prevention of Chronic Migraine James E. FramptonStephen Silberstein Adis Drug Evaluation Open access 12 March 2018 Pages: 589 - 600
Correction to: Eculizumab: A Review in Generalized Myasthenia Gravis Sohita Dhillon Correction Open access 09 March 2018 Pages: 607 - 607
Correction to: Treatment of Tardive Dyskinesia: A General Overview with Focus on the Vesicular Monoamine Transporter 2 Inhibitors Nicki NiemannJoseph Jankovic Correction 10 March 2018 Pages: 609 - 609